Venus Remedies Limited , a leading research-driven pharmaceutical company, has once again received the World Health Organization (WHO) Good Distribution Practices (GDP) Certification for its ... Jul 18
The QIDP designation by the United States Food and Drug Administration (US FDA) underscores the urgent global need for safer polymyxin-based therapies... Apr 17
MET-X, a novel metallo-beta-lactamase (MBL) inhibitor, has shown best-in-class performance in preclinical studies and could be game-changing for patients ... Feb 25
The company has received marketing authorisation for docetaxel from Israel and cytarabine from Colombia. This significant milestone underscores Venus Remedies' commitment to making a substantial ... Dec 29
Venus Remedies makes its maiden entry into Azerbaijan’s pharmaceutical market. The company has over a dozen marketing authorisations for enoxaparin worldwide... Dec 13
The $4.20-billion pharmaceutical market of the Philippines accounts for a significant market for Venus Remedies from the ASEAN region as the company moves ... Nov 04
As the first pharmaceutical company in India to be honored with the REO certification from CII, Venus Remedies stands at the forefront of responsible and ... Nov 04
The Ecuador antibiotics market is majorly dependent on imports from India. Ecuador had imported antibiotics worth US $3.5 million in 2022. The launch of ... Nov 03
-Advertisements-
.jpeg)
Tuesday, August 11, 2026
.png)
.jpg)
.jpg)
.jpg)
